Abstract
Cognitive dysfunction underpins some of the psychopathology of schizophrenia, as well as contributes to the patient's impaired social and vocational functioning and has now been recognized as an intrinsic dimension linked to functional outcome. Despite a general consensus on the capacity of antipsychotics to improve the psychopathology of schizophrenia, the dispute concerning their impact on cognitive function is constantly open.
We performed a selective review on the possible effects of antipsychotics, both of first and second generation, for a cognitive performance improvement. Other than the strict treatment, pharmacological effect and related aspects, such as dosage and pharmaco-induced brain structure modifications, placebo and practice effect issues have been considered. Interaction with specific cognitive interventions, such as remediation programs and enhancement treatments are discussed. On the basis of the current evidence-based findings, the hypothesis that cognition could be substantially influenced by antipsychotics has so far been demonstrated. Administering antipsychotic medications in an individually optimized manner seems to have the potential of improving cognitive aspects of schizophrenia, regardless of the kind of antipsychotic medication.Keywords: Medication management, antipsychotic agents, cognition, placebo, practice effect, cognitive remediation, cognitive enhancement
Current Psychopharmacology
Title:Antipsychotics and Cognitive Functioning: A Critical Review
Volume: 2
Author(s): Paolo Stratta, Ilaria Riccardi and Alessandro Rossi
Affiliation:
Keywords: Medication management, antipsychotic agents, cognition, placebo, practice effect, cognitive remediation, cognitive enhancement
Abstract: Cognitive dysfunction underpins some of the psychopathology of schizophrenia, as well as contributes to the patient's impaired social and vocational functioning and has now been recognized as an intrinsic dimension linked to functional outcome. Despite a general consensus on the capacity of antipsychotics to improve the psychopathology of schizophrenia, the dispute concerning their impact on cognitive function is constantly open.
We performed a selective review on the possible effects of antipsychotics, both of first and second generation, for a cognitive performance improvement. Other than the strict treatment, pharmacological effect and related aspects, such as dosage and pharmaco-induced brain structure modifications, placebo and practice effect issues have been considered. Interaction with specific cognitive interventions, such as remediation programs and enhancement treatments are discussed. On the basis of the current evidence-based findings, the hypothesis that cognition could be substantially influenced by antipsychotics has so far been demonstrated. Administering antipsychotic medications in an individually optimized manner seems to have the potential of improving cognitive aspects of schizophrenia, regardless of the kind of antipsychotic medication.Export Options
About this article
Cite this article as:
Stratta Paolo, Riccardi Ilaria and Rossi Alessandro, Antipsychotics and Cognitive Functioning: A Critical Review, Current Psychopharmacology 2013; 2 (1) . https://dx.doi.org/10.2174/2211556011302010037
DOI https://dx.doi.org/10.2174/2211556011302010037 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Natural Monophenols as Therapeutics, Antioxidants and Toxins; Electron Transfer, Radicals and Oxidative Stress
The Natural Products Journal Non-viral Gene Delivery and Therapeutics Targeting to Brain
Current Nanoscience Huntingtons Disease: The Value of Transcranial Meganetic Stimulation
Current Medicinal Chemistry Advances in Mucomodulator Therapy for Treatment of Excess Airway Mucus in Patients with Asthma, Chronic Obstructive Pulmonary Disease and Cystic Fibrosis
Recent Patents on Materials Science Substance Abuse and Movement Disorders
Current Drug Abuse Reviews Effects of Alcohol in the Lung
Current Respiratory Medicine Reviews Curcumin: the Yellow Molecule with Pleiotropic Biological Effects
Letters in Drug Design & Discovery Antipsychotics in Obsessive-Compulsive Disorder
Current Psychiatry Reviews Olanzapine Loaded Cationic Solid Lipid Nanoparticles for Improved Oral Bioavailability
Current Nanoscience Antidepressant Related Movement Disorders in the Elderly
Current Psychiatry Reviews Nitric Oxide Production during Cerebral Ischemia and Reperfusion in eNOS- and nNOS-Knockout Mice
Current Neurovascular Research Molecular Genetic of Human Male Infertility: From Genes to New Therapeutic Perspectives
Current Pharmaceutical Design Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery AtreMorine Treatment Regulates DNA Methylation in Neurodegenerative Disorders: Epigenetic and Pharmacogenetic Studies
Current Pharmacogenomics and Personalized Medicine Editorial [ Hot Topic: Drugs Targets in Parkinson's Disease:Where Are We and Where should We Go? (Guest Editor: Mark R. Cookson)]
CNS & Neurological Disorders - Drug Targets Therapeutic Potential, Synthesis, Patent Evaluation and SAR Studies of Thieno[3,2-d]pyrimidine Derivatives: Recent Updates
Current Drug Targets Pulmonary Defence Mechanisms
Current Respiratory Medicine Reviews Urine Cells-derived iPSCs: An Upcoming Frontier in Regenerative Medicine
Current Medicinal Chemistry Oxidative Stress and Antioxidant Potential of One Hundred Medicinal Plants
Current Topics in Medicinal Chemistry Aggregation State and Neurotoxic Properties of Alzheimer β-Amyloid Peptide
Current Protein & Peptide Science